Prendergast Mark A, Rogers D Trent, Mulholland Patrick J, Littleton John M, Wilkins Lincoln H, Self Rachel L, Nath Avindra
Department of Psychology, University of Kentucky, 115 Kastle Hall, Lexington, KY 40506-0044, USA.
Brain Res. 2002 Nov 8;954(2):300-7. doi: 10.1016/s0006-8993(02)03360-7.
Human immunodeficiency virus type-I (HIV-1) infection is often associated with neuronal loss in cortical and subcortical regions that may manifest as motor dysfunction and dementia. The function of the HIV-1 transcription protein Tat and subsequent activation of N-methyl-D-aspartate receptors (NMDAr) have been implicated in this form of neurodegeneration. However, it is unclear if Tat interacts directly with the NMDAr and the role of specific NMDAr subunit composition in mediating effects of Tat is also unclear. The present studies examined the ability of HIV-1 Tat1-72 protein (10 pM-1.0 microM) to displace [3H]MK-801 binding and to attenuate spermidine-induced potentiation of this binding in rat brain homogenate comprised of cerebellum, hippocampus, and cerebral cortex. The role of NMDAr polyamine-site function in the neurotoxic effects of Tat was determined using organotypic hippocampal slice cultures. Binding of [3H]MK-801 in adult rat brain homogenate was not reduced by Tat at concentrations below 1 microM. Tat potently inhibited the potentiation of [3H]MK-801 binding produced by co-exposure of membranes to the NMDAr co-agonist spermidine (IC(50)=3.74 nM). In hippocampal explants, Tat produced neurotoxicity in the CA3 and CA1 pyramidal cell layers, as well as in the dentate gyrus, that was significantly reduced by co-exposure to MK-801 (20 microM) and the NMDAr polyamine-site antagonist arcaine (10 microM). Exposure to the HIV-1 Tat deletion mutant (Tatdelta31-61) did not produce neurotoxicity in hippocampal explants. These data suggest that the neurotoxic effects of HIV-1 Tat are mediated, in part, by direct interactions with a polyamine-sensitive site on the NMDAr that positively modulates the function of this receptor.
I型人类免疫缺陷病毒(HIV-1)感染常与皮质和皮质下区域的神经元丧失有关,这可能表现为运动功能障碍和痴呆。HIV-1转录蛋白Tat的功能以及随后N-甲基-D-天冬氨酸受体(NMDAr)的激活与这种神经退行性变形式有关。然而,尚不清楚Tat是否直接与NMDAr相互作用,并且特定NMDAr亚基组成在介导Tat效应中的作用也不清楚。本研究检测了HIV-1 Tat1-72蛋白(10 pM - 1.0 microM)在由小脑、海马和大脑皮质组成的大鼠脑匀浆中取代[3H]MK-801结合以及减弱亚精胺诱导的该结合增强的能力。使用海马器官型脑片培养物确定NMDAr多胺位点功能在Tat神经毒性作用中的作用。在浓度低于1 microM时,Tat不会降低成年大鼠脑匀浆中[3H]MK-801的结合。Tat能有效抑制膜与NMDAr共激动剂亚精胺共同暴露所产生的[3H]MK-801结合增强(IC(50)=3.74 nM)。在海马外植体中,Tat在CA3和CA1锥体细胞层以及齿状回中产生神经毒性,与MK-801(20 microM)和NMDAr多胺位点拮抗剂阿卡因(10 microM)共同暴露可显著降低这种神经毒性。暴露于HIV-1 Tat缺失突变体(Tatdelta31-61)不会在海马外植体中产生神经毒性。这些数据表明,HIV-1 Tat的神经毒性作用部分是通过与NMDAr上对多胺敏感的位点直接相互作用介导的,该位点正向调节该受体的功能。